On November 13th EyeOn hosted an idealab on the impact of MDR (=Medical Device Regulation) on supply chain planning processes in Brussels.
After a brief clarification on the new EU MDR regulations and an introduction on the planning impact, participants discussed the elements to consider from a supply planning perspective.
Regulatory aspects, timing of registrations, portfolio review, integration of MDR changes in the S&OP cycle, master data management, demand and supply risks were some of the topics that were considered as points of attention for a proper supply chain integration of MDR regulations.
Participants confirmed the impact of MDR on supply chain planning is severely underestimated and emphasized MDR is more than a QA/RA topic.
MDR really needs to be addressed cross departmental with senior management attention on systematic risk review.
For more information about MDR and its impact on planning you can contact Vasco Werners, Luc van Wouwe, or Loek Lemmens.